STERIS plc
For the period ended Mar 31, 2026. Filed May 29, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed May 29, 2026
STE$257.12+0.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
(in millions)
| Years Ended March 31, | 2026 | 2025 | 2024 |
|---|---|---|---|
| Operating activities: | |||
| Net income | $785.1 | $616.1 | $380.1 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Depreciation, depletion, and amortization | 486.5 | 476.2 | 565.2 |
| Deferred income taxes | (16.9) | (76.5) | (131.4) |
| Share-based compensation expense | 61.7 | 57.4 | 56.5 |
| Loss on the disposal of property, plant, equipment, and intangibles, net | 3.6 | 5.7 | 25.0 |
| Loss on classification as held for sale | — | — | 206.4 |
| (Gain) loss on sale of businesses and investments, net | (0.3) | 6.4 | 0.3 |
| Amortization of inventory fair value adjustments | — | — | 4.8 |
| Other items | (5.6) | (3.7) | 12.3 |
| Changes in operating assets and liabilities, net of effects of acquisitions and divestitures: | |||
| Accounts receivable, net | (25.1) | (28.8) | (128.1) |
| Inventories, net | (24.0) | 73.1 | (37.5) |
| Other current assets | (22.7) | (50.3) | (1.6) |
| Accounts payable | 51.1 | 33.6 | (19.0) |
| Accruals and other, net | 47.8 | 38.9 | 40.0 |
| Net cash provided by operating activities | 1,341.4 | 1,148.1 | 973.3 |
| Investing activities: | |||
| Purchases of property, plant, equipment, and intangibles | (369.0) | (370.1) | (360.3) |
| Proceeds from the sale of property, plant, equipment, and intangibles | 10.5 | 9.2 | 7.4 |
| Proceeds from the sale of businesses | — | 814.6 | 9.5 |
| Proceeds from the sale of investments | — | — | 3.9 |
| Purchases of investments | (134.0) | (10.8) | (1.5) |
| Acquisition of businesses, net of cash acquired | (20.1) | (54.1) | (546.3) |
| Net cash (used in) provided by investing activities | (512.5) | 388.8 | (887.4) |
| Financing activities: | |||
| Payments on term loans | — | (638.1) | (60.0) |
| Payments on Private Placement Senior Notes | (125.0) | (80.0) | — |
| Proceeds (payments) under credit facilities, net | 3.0 | (446.3) | 181.5 |
| Deferred financing fees and debt issuance costs | — | (2.3) | — |
| Acquisition related deferred or contingent consideration | (0.4) | (0.4) | (6.2) |
| Repurchases of ordinary shares | (235.5) | (211.3) | (11.8) |
| Cash dividends paid to ordinary shareholders | (241.8) | (219.9) | (200.6) |
| Distributions to noncontrolling interest holders | (1.4) | (2.1) | (1.6) |
| Contributions from noncontrolling interest holders | — | 2.5 | 3.0 |
| Stock option and other equity transactions, net | 32.9 | 25.5 | 10.5 |
| Net cash used in financing activities | (568.2) | (1,572.4) | (85.2) |
| Effect of exchange rate changes on cash and cash equivalents | 7.2 | 0.2 | (2.1) |
| Increase (decrease) in cash and cash equivalents | 267.9 | (35.3) | (1.3) |
| Cash and cash equivalents at beginning of period | 171.7 | 207.0 | 208.4 |
| Cash and cash equivalents at end of period | $439.6 | $171.7 | $207.0 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.